A
Apogee Therapeutics
APGE · NASDAQ · Healthcare
$134.65
+$0.16 (+0.12%) today
Loading live data...
Market Cap
$10.18B
24h Volume
$144.9M
P/E Ratio
0.0
52w High
$134.65
52w Low
$34.65
Est. AI Revenue
80%
Loading chart data...
7-Day Sparkline (Static)
About Apogee Therapeutics
Clinical-stage biotech using AI-guided antibody engineering for atopic dermatitis and inflammatory diseases with computationally optimized biologics.
CEO: Michael Henderson
Founded: 2022
HQ: San Francisco, California
Employees: 261
Performance
24 Hours+0.12%
7 Days+0.42%
30 Days+0.81%
1 Year+274.03%